LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Company News/Scott Mains Named VP of Sales of NextStep Arthropedix
Company News

Scott Mains Named VP of Sales of NextStep Arthropedix

January 19, 2023 2 min read Premium comments

Advertisement

Scott Mains Named VP of Sales of NextStep Arthropedix
Scott Mains / Courtesy of Scott Mains
Secondary#nextsteparthropedix#insituhipsystem#scottmains

Orthopedic sales management professional Scott Mains has been named vice president of sales of NextStep Arthropedix, a medical device manufacturer based in Akron, Ohio.

OTW spoke with Mains about his new role. Mains told OTW that what he is looking forward to most in his new role is “helping position a forward-thinking reconstructive company like Nextstep at the forefront of a very commoditized market.”

Mains added, “As a smaller company in this space we know that everything we do must be creating value to our surgeons and patients and that is exactly what we intend to do.”

Mains is a familiar face at NextStep and has been with the company for four years. Most recently he served as vice president of sales – east U.S. He joined NextStep in 2019 as area vice president – northeast. After 18 months in that role, he transitioned to area vice president – east.

Mains has worked in sales roles at other notable companies including Smith & Nephew Orthopaedics and Biomet. Prior to joining NextStep he spent over four years with Smith & Nephew Orthopaedics as a district sales manager. Before that he was a territory sales manager for Biomet for nearly a decade. He joined Biomet from Smith & Nephew Orthopaedics where he spent over three years as a sales consultant.

NextStep focuses on the design, development and manufacturing of joint replacement implants and instrument products for hip and knee arthroplasty. The company incorporates 3D printing technology in its design and manufacturing processes and has formed several new divisions focused on medical ceramics, antimicrobials, and microelectronics.

In 2017 NextStep launched its flagship iNSitu™ Hip Systems and since has added several new product lines: iNSitu™ Blade Hip System, iNSitu™ Cemented Stem, iNSitu™ Bipolar Hip System, iNSitu™ Multi-Hole 3D printed cup. In 2023, NextStep will launch two new products, a new collared hip stem system and kinematic knee system.

NextStep Arthropedix was founded in 2014 by entrepreneur Randy Theken, who made his first appearance in the medical device market out of graduate school in 1992. From 1992-2009 Theken founded several spinal implant companies that were acquired in 2009 and developed the world’s first orthopedic implant (replacement disc) with embedded active microelectronics in 2003.

Advertisement

Theken told OTW, “I would like to congratulate Scott on his new position and I’m excited to work even closer with Scott allowing him autonomy to drive the sales initiative at NextStep.”

For OTW’s prior coverage of NextStep, see “Randy Theken’s New Company and Return to Orthopedics.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy